RENE.L - ReNeuron Group plc

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
783
530
403
257
6,065
Operating expenses
Research development
6,714
4,463
8,068
6,004
16,335
Selling general and administrative
1,065
1,131
1,127
728
1,914
Total operating expenses
10,212
7,644
11,628
12,566
20,574
Operating income or loss
-9,429
-7,114
-11,225
-12,309
-14,509
Interest expense
17
20
25
516
42
Income before tax
-8,912
-6,657
-11,058
-13,410
-13,858
Income tax expense
-1,281
-1,249
-1,369
-2,063
-2,446
Income from continuing operations
-7,631
-5,408
-9,689
-11,347
-11,412
Net income
-7,631
-5,408
-9,689
-11,347
-11,412
Net income available to common shareholders
-7,631
-5,408
-9,689
-11,347
-11,412
Basic EPS
-
-0.10
-0.17
-0.29
-0.36
Diluted EPS
-
-0.10
-0.17
-0.29
-0.36
Basic average shares
-
57,126
56,976
39,129
31,811
Diluted average shares
-
57,126
56,976
39,129
31,811
EBITDA
-
-6,370
-10,709
-12,514
-13,404